Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof: wherein each symbol is as defined in the attached DESCRIPTION.

Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.

Abstract: A maintenance support device for supporting maintenance of an apparatus includes a communication interface configured to perform communication with the apparatus through a communication cable and to feed electric power to the apparatus; and an information obtaining portion configured to obtain from the apparatus, while the apparatus is fed with the electric power, pre-replacement individual identification information and post-replacement individual identification information for a target component for replacement work on the apparatus by communication using the communication interface.

Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof: wherein each symbol is as defined in the attached DESCRIPTION.

Abstract: An image forming apparatus includes: a first communication unit configured to perform communication by a short-distance wireless method; a second communication unit having a broader communication range than the first communication unit; a storage unit configured to store data to which an access right of a first user is set; a connection information providing unit configured to, when a data providing command for providing the data from a first terminal device of the first user to another user is received, and an access request to the data is received from a second terminal device of a second user, transmit connection information for accessing the data to the second terminal device; and a data providing unit configured to transmit the data to the second terminal device by the second communication unit, when a transmission request of the data is received from the second terminal device based on the connection information.

Abstract: An information processing apparatus includes a hardware processor. The hardware processor executes an firmware of a first version, acquires a set of firmware of a second version and verification state information that indicates progress of verification of each of a plurality of processes defined by the firmware of the second version from a server, and updates the firmware of the first version with the firmware of the second version. The verification state information includes a completed state where the verification of a non-occurrence of an error is completed and an unverified state where the verification of the non-occurrence of an error is not completed, and the hardware professor sets a settability state of an unverified process out of the plurality of processes to a disabled state where a user cannot make settings to allow execution of the unverified process.

Abstract: Provided is a compound having a cholinergic muscarine M1 receptor positive allosteric modulator activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a cholinergic muscarine M1 receptor positive allosteric modulator activity, and is useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like.

Abstract: An information processing apparatus to which a plurality of users can log in includes: a display unit configured to display an image; and a display controller configured to display personal region images corresponding to the respective users in a plurality of personal display regions at different positions in a display face of the display unit, display common images in the same common display region among the users in the display face of the display unit, and display images of data acquired on the authority to access of a corresponding user in the personal display regions to be movable, respectively, wherein when any of the users logs out, the display controller finishes displaying the image arranged in the personal display region among the data acquired on the authority to access of the user who logs out, and continues to display the image arranged in the common display region.

Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as medicaments such as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like, and the like. The present invention relates to a compound represented by the formula (I) wherein ring A is an optionally substituted 5- or 6-membered ring; R is a C1-6 alkyl group substituted by 1 to 5 halogen atoms; and X is —CH? or —N?, or a salt thereof.

Abstract: A multifunction device integrally includes a first device and a second device. The first device has a first system, and the second system has a second system. The second device requests, in response to a predetermined command entered, a first snapshot of the first device from the first device. The first device generates the first snapshot in response to a request from the second device, and sends the first snapshot to the second device. The second device generates a second snapshot of the second device in response to the predetermined command entered, and saves, to a save destination, the first snapshot sent and the second snapshot. The first device starts the first system by using the first snapshot saved in the save destination. The second device starts the second system by using the second snapshot saved in the save destination.

Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof: wherein each symbol is as defined in the attached DESCRIPTION.

Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.

Abstract: The present invention provides a compound which has a cholinergic muscarinic M1 receptor positive allosteric modulator activity and may be useful as a medicament such as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, Lewy body dementia and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. In the formula (I), each symbol is as described in the attached specification.

Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof: wherein each symbol is as defined in the attached DESCRIPTION.

Abstract: An image processing apparatus includes a main processor configured to process packets received by a wired LAN module and a wireless LAN module in a normal state and a sub processor configured to process packets received by the wired LAN module and the wireless LAN module in place of the main processor in a first power saving state in which supply of electric power to the main processor is stopped. In the first power saving state, the sub processor is configured to process a packet received by the wired LAN module by using a first combination of a MAC address and an IP address and to process a packet received by the wireless LAN module by using a second combination of a MAC address and an IP address.

Abstract: An image processing apparatus includes a display unit that displays a preview image of a document on a preview screen during login of a first user, a communication controller that receives a job from an external device, a determination unit that determines whether the job received from the external device is a specific type of job, and a display controller that controls display on the preview screen. When the specific type of job is received during display of the preview screen, the display controller assumes a predetermined degree or more of possibility that a second user different from the first user may approach the apparatus, and performs at least one of first display control where the preview image is automatically hidden on the preview screen and second display control where a non-display button for hiding the preview image according to a user operation is displayed on the preview screen.

Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof: wherein each symbol is as defined in the attached DESCRIPTION.

Abstract: A communication device includes a main controller and a second controller that responds, independently of the main controller, to received data based on a proxy program. The communication device also includes a storage that stores, every time data is received, a combination of attributes of the data and details of a response to the data made by the main controller. The communication device also includes a generating circuit that determines at least one pattern with which a response, independently of the main controller, is possible based on a plurality of combinations stored in the storage to generate the proxy program based on the pattern determined. The communication device also includes an applying circuit that applies the proxy program generated by the generating circuit to the second controller.

Abstract: One information processing apparatus among a plurality of information processing apparatuses performs virus detection processing for detecting a computer virus. When a computer virus has been detected from the one information processing apparatus by the virus detection processing, the one information processing apparatus transmits an execution request to perform the virus detection processing to another information processing apparatus different from the one information processing apparatus among the plurality of information processing apparatuses.

Abstract: An MFP sets an access condition for an external device with respect to a cloud box. The access condition is transmitted from the MFP to a relay device, and is registered in a memory of the relay device. When the relay device receives an access request made by the external device with respect to the MFP serving as an internal device, the relay device determines whether to permit or deny access to the MFP by comparing the access request with the access condition. When the access is permitted, the access request is transferred from the relay device to the MFP, whereas when the access is denied, the relay device notifies the external device of it.